Intellia Therapeutics Inc buy Morgan Stanley
Start price
13.11.23
/
50%
€21.86
Target price
13.11.24
€79.49
Performance (%)
-29.07%
End price
14.11.24
€15.51
Summary
This prediction ended on 14.11.24 with a price of €15.51. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.07%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -1.907% | -1.907% | -6.728% |
| iShares Core DAX® | 2.591% | 2.467% | 8.839% |
| iShares Nasdaq 100 | -0.915% | -6.458% | 24.933% |
| iShares Nikkei 225® | 0.145% | -8.773% | 47.385% |
| iShares S&P 500 | -0.367% | -1.220% | 21.667% |
Comments by Morgan_Stanley for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Morgan Stanley from $90.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten